All stories tagged :

People

Hyaluronic Acid Based Dermal Fillers Market Analysis Report 2025: Influencers Normalize...

admin
People

Softwood Global Strategic Business Report 2024: Increasing Demand for Sustainable and...

admin
People

Vietnam In Vitro Fertilization (IVF) Market Analysis, Competition, Forecasts and Opportunities,...

admin
People

Bel Group and Dassault Systèmes partner to accelerate the food industry...

admin
People

2024 Fitzgerald Prize Laureate Announced at Hôtel Belles Rives

admin
People

[Latest] Global Adventure Tourism Market Size/Share Worth USD 2600 Billion by...

admin
People

2024 Top Trends Shaping the Beauty and Personal Care Industry: Premiumisation...

admin
People

Fermentation Chemicals Market Size to Worth USD 166.33 Billion by 2033

admin
People

Global Colored Contact Lenses Market Size To Worth USD 9.82 Billion...

admin
People

United Kingdom Consumer Values and Behaviour Insights Report 2024: Linking Behavioural...

admin
People

MINILUXE ANNOUNCES JV AND MAJORITY OWNERSHIP OF NEW ATLANTA SITE WITH...

admin

Featured

Pr Newswire

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a...

admin
Pr Newswire

Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate...

admin
Pr Newswire

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001...

admin
Pr Newswire

aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis

admin
admin

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a...

ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three patients in the 550 mg twice daily cohort in the ongoing...